J Benger1, D Coates2, S Davies3, R Greenwood4, J Nolan5, M Rhys6, M Thomas7, S Voss3. 1. Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK jonathan.benger@uwe.ac.uk. 2. GP Out of Hours Service, BrisDoc Healthcare Services, Bristol, UK. 3. Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK. 4. Research Design Service - South West, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. 5. Department of Anaesthesia and Intensive Care Medicine, Royal United Hospital Bath NHS Foundation Trust, Bath, UK. 6. Research and Audit, South Western Ambulance Service NHS Foundation Trust, Exeter, UK. 7. Intensive Care Medicine, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Abstract
BACKGROUND: The best initial approach to advanced airway management during out of hospital cardiac arrest (OHCA) is unknown. The traditional role of tracheal intubation has been challenged by the introduction of supraglottic airway devices (SGAs), but there is contradictory evidence from observational studies. We assessed the feasibility of a cluster-randomized trial to compare the i-gel SGA vs the laryngeal mask airway supreme (LMAS) vs current practice during OHCA. METHODS: We conducted a cluster-randomized trial in a single ambulance service in England, with individual paramedics as the unit of randomization. Consenting paramedics were randomized to use either the i-gel or the LMAS or usual practice for all patients with non-traumatic adult OHCA, that they attended over a 12-month period. The primary outcome was study feasibility, including paramedic and patient recruitment and protocol adherence. Secondary outcomes included survival to hospital discharge and 90 days. RESULTS: Of the 535 paramedics approached, 184 consented and 171 attended study training. Each paramedic attended between 0 and 11 patients (median 3; interquartile range 2-5). We recruited 615 patients at a constant rate, although the LMAS arm was suspended in the final two months following three adverse incidents. The study protocol was adhered to in 80% of patients. Patient characteristics were similar in the three study arms, and there were no differences in secondary outcomes. CONCLUSION: We have shown that a prospective trial of alternative airway management strategies in OHCA, cluster randomized by paramedic, is feasible. CLINICAL TRIAL REGISTRATION: Registered on the International Standard Randomised Controlled Trial Registry ( ISRCTN: 18528625).
BACKGROUND: The best initial approach to advanced airway management during out of hospital cardiac arrest (OHCA) is unknown. The traditional role of tracheal intubation has been challenged by the introduction of supraglottic airway devices (SGAs), but there is contradictory evidence from observational studies. We assessed the feasibility of a cluster-randomized trial to compare the i-gel SGA vs the laryngeal mask airway supreme (LMAS) vs current practice during OHCA. METHODS: We conducted a cluster-randomized trial in a single ambulance service in England, with individual paramedics as the unit of randomization. Consenting paramedics were randomized to use either the i-gel or the LMAS or usual practice for all patients with non-traumatic adult OHCA, that they attended over a 12-month period. The primary outcome was study feasibility, including paramedic and patient recruitment and protocol adherence. Secondary outcomes included survival to hospital discharge and 90 days. RESULTS: Of the 535 paramedics approached, 184 consented and 171 attended study training. Each paramedic attended between 0 and 11 patients (median 3; interquartile range 2-5). We recruited 615 patients at a constant rate, although the LMAS arm was suspended in the final two months following three adverse incidents. The study protocol was adhered to in 80% of patients. Patient characteristics were similar in the three study arms, and there were no differences in secondary outcomes. CONCLUSION: We have shown that a prospective trial of alternative airway management strategies in OHCA, cluster randomized by paramedic, is feasible. CLINICAL TRIAL REGISTRATION: Registered on the International Standard Randomised Controlled Trial Registry ( ISRCTN: 18528625).
Authors: M Christ; K I von Auenmüller; T von den Benken; S Fessaras; W Dierschke; H-J Trappe Journal: Med Klin Intensivmed Notfmed Date: 2018-10-23 Impact factor: 0.840
Authors: M Bernhard; N H Behrens; J Wnent; S Seewald; S Brenner; T Jantzen; A Bohn; J T Gräsner; M Fischer Journal: Anaesthesist Date: 2018-01-04 Impact factor: 1.041
Authors: Lars W Andersen; Asger Granfeldt; Clifton W Callaway; Steven M Bradley; Jasmeet Soar; Jerry P Nolan; Tobias Kurth; Michael W Donnino Journal: JAMA Date: 2017-02-07 Impact factor: 56.272
Authors: Jonathan R Benger; Kim Kirby; Sarah Black; Stephen J Brett; Madeleine Clout; Michelle J Lazaroo; Jerry P Nolan; Barnaby C Reeves; Maria Robinson; Lauren J Scott; Helena Smartt; Adrian South; Elizabeth A Stokes; Jodi Taylor; Matthew Thomas; Sarah Voss; Sarah Wordsworth; Chris A Rogers Journal: Health Technol Assess Date: 2022-04 Impact factor: 4.106
Authors: Matthew Lee Hansen; Adam Wagner; Ashley Schnapp; Amber Lin; Nancy Le; Sarah Deverman; Elizabeth Pedigo; Andrea Johnson; Jordan Cusick; Heike Gries; Meredith Kato Journal: Emerg Med J Date: 2020-10-12 Impact factor: 2.740
Authors: Jonathan R Benger; Kim Kirby; Sarah Black; Stephen J Brett; Madeleine Clout; Michelle J Lazaroo; Jerry P Nolan; Barnaby C Reeves; Maria Robinson; Lauren J Scott; Helena Smartt; Adrian South; Elizabeth A Stokes; Jodi Taylor; Matthew Thomas; Sarah Voss; Sarah Wordsworth; Chris A Rogers Journal: JAMA Date: 2018-08-28 Impact factor: 56.272
Authors: Stephanie Armstrong; Adele Langlois; Despina Laparidou; Mark Dixon; Jason P Appleton; Philip M Bath; Helen Snooks; A Niroshan Siriwardena Journal: BMC Med Res Methodol Date: 2017-09-16 Impact factor: 4.615